A Simultaneous Assessment of Efficacy and Safety of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease

Clinical Therapeutics · Published 2026-05-15 · DOI 10.1016/j.clinthera.2026.04.007

Free full text

Authors (8)

Daniel Dorgan, Catherine Waweru, Kim Cocks, Rachael Lawrance, Matthias Hunger, Ankit Pahwa, Dayton W. Yuen, Leona E. Markson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Dorgan, D., Waweru, C., Cocks, K., et al. (2026). A Simultaneous Assessment of Efficacy and Safety of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2026.04.007

Related articles